Identification of Novel Micropeptides Derived from Hepatocellular Carcinoma-Specific Long Noncoding RNA

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Cancer-specific target molecules and biomarkers are crucial for developing novel treatments and immunotherapies.
• Long noncoding RNAs (lncRNAs) exhibit cancer-type specificity due to chromatin remodeling and alternative splicing.
• A previously identified small protein, C20orf204-189AA, encoded by the lncRNA Linc00176, supports hepatocellular carcinoma (HCC) growth.

Purpose of the Study:

• To identify novel micropeptides encoded by HCC-specific lncRNAs.
• To investigate the functional role of these micropeptides in HCC.
• To explore the potential of these micropeptides as cancer-specific target molecules.

Main Methods:

• RNA-sequencing and polysome profiling were employed to identify micropeptides from lncRNAs.
• DNase-sequencing was used to analyze chromatin structure alterations.
• Peptide-specific antibody generation and characterization were performed for candidate micropeptides.

Main Results:

• Nine lncRNAs exclusively expressed in HCC cells were identified.
• Altered chromatin structure was found to be key in the HCC-specific expression of these lncRNAs.
• One lncRNA, Linc013026, was shown to encode a 68 amino acid micropeptide (Linc013026-68AA) that enhances HCC cell proliferation.

Conclusions:

• Linc013026-68AA is a novel micropeptide expressed in a subset of HCC cells.
• Linc013026-68AA plays a role in HCC cell proliferation, indicating its potential as a therapeutic target.
• These findings highlight the significance of the 'dark proteome' originating from noncoding regions in cancer development.